We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New AI Software Facilitates Earlier Brain CT Detection and Triage of Obstructive Hydrocephalus

By MedImaging International staff writers
Posted on 14 Sep 2023
Image: The first ever radiology triage device has been awarded FDA Breakthrough Devices Designation (Photo courtesy of Annalise.ai)
Image: The first ever radiology triage device has been awarded FDA Breakthrough Devices Designation (Photo courtesy of Annalise.ai)

Obstructive hydrocephalus (OHCP), a critical medical condition, occurs when cerebrospinal fluid builds up in the brain, causing a rapid increase in intracranial pressure that can become dangerous if not addressed promptly. Now, an AI-powered medical imaging solution has been designed for the triage and notification of OHCP on non-contrast brain CT scans.

Annalise.ai (Sydney, Australia) has obtained 510(k) FDA clearance for its AI-based system for the triage and notification of OHCP in non-contrast brain CT images. In addition, the company's software tool for OHCP has been granted the FDA's Breakthrough Device Designation, making it the first radiology triage tool to receive this recognition since the launch of the FDA Breakthrough Devices Program. This advanced technology from Annalise.ai features both passive and active alert mechanisms for potential OHCP cases detected in unenhanced head CT scans. This latest approval expands the company’s range of FDA-cleared products in the United States to ten FDA-cleared findings – five for chest X-rays (CXR) and five for head CT scans (CTB). This positions Annalise.ai as one of the most comprehensive providers of FDA-cleared AI-based triage solutions in the U.S.

“Our FDA clearances, including this latest addition, underscore our dedication to revolutionizing medical imaging,” said Lakshmi Gudapakkam, CEO of Annalise.ai. “Annalise.ai is proud to offer a comprehensive suite of AI solutions that significantly enhance diagnostic capabilities and assist in delivering prompt, life-saving interventions for conditions like obstructive hydrocephalus.”

“Our advanced algorithms support radiologists by facilitating prioritization of non-contrast head CT studies with suspected critical findings, thereby optimizing radiology workflow,” added Dr Rick Abramson, Chief Medical Officer at Annalise.ai. With its set of clearances, Annalise.ai promotes faster report turnaround times by identifying and elevating critical cases for immediate attention.”

Related Links:
Annalise.ai

Mammo DR Retrofit Solution
DR Retrofit Mammography
Diagnostic Ultrasound System
DC-80A
Digital Intelligent Ferromagnetic Detector
Digital Ferromagnetic Detector
Digital X-Ray Detector Panel
Acuity G4

Channels

Nuclear Medicine

view channel
Image: LHSCRI scientist Dr. Glenn Bauman stands in front of the PET scanner (Photo courtesy of LHSCRI)

New Imaging Solution Improves Survival for Patients with Recurring Prostate Cancer

Detecting recurrent prostate cancer remains one of the most difficult challenges in oncology, as standard imaging methods such as bone scans and CT scans often fail to accurately locate small or early-stage tumors.... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.